Ceftriaxone (Ro 13-9904) therapy of serious infection.
Ceftriaxone (Ro 13-9904), a newly developed cephalosporin with a long half-life, was evaluated for efficacy and safety in 19 patients with serious infections. Underlying illnesses were present in 16 patients. Ceftriaxone was given intravenously every 12 h. Infections treated included gram-negative b...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1982
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC183670/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6289739/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.1.36 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|